Our Impact
GLP-1 therapies are transforming the future of healthcare and so are we.
GLP-1 therapies are transforming the future of healthcare and so are we.
At the GLP-1 Collective, we are leading efforts to expand access, raise awareness, and build a healthier tomorrow. Explore our journey, our current initiatives, and the future we’re shaping — and see how your support can drive lasting change.
Our History
Since our founding, the GLP-1 Collective has been fueled by a single mission: making GLP-1 medications accessible for everyone who needs them. From grassroots advocacy to national momentum, our milestones reflect the strength of a growing community determined to break down barriers and change healthcare access for the better.
-
In November of 2024 we launched a petition to fight for affordable access to GLP-1s
-
Our petition was featured in the Politico highlighting the ongoing shortage and the challenge of tracking the full number of GLP-1 patients.
-
In November our petition was featured in USA Today, highlighting the fight for affordable GLP-1s and the role of compounding pharmacies in expanding access.
-
In December, our founder was featured on ABC’s Local 5 News, highlighting our petition and the vital role of compounding pharmacies in affordable GLP-1 access.
-
In December, our petition was featured in a CNBC article, this time highlighting the urgent need for preventive care, and how current insurance coverage often only begins after patients are already in crisis.
-
In December, we launched the GLP-1 Collective Podcast. This is a platform where brand-name and compound users share personal stories about how these medications have been both life-changing and life-saving.
-
In early January, the GLP-1 Collective officially registered as a nonprofit, centralizing our advocacy efforts, building a membership platform, and deepening our commitment to affordable access for all.
-
In February, the GLP-1 Collective was officially recognized as a 501(c)(3) tax-exempt charitable nonprofit, retroactive to January 10, 2025.
This was a major milestone in our mission to fight for affordable access. -
In March, the GLP-1 Collective was featured in USA Today, underscoring the growing crisis as compounded GLP-1 options vanish, driving up costs and reducing access for patients who depend on affordable alternatives.
Current Programs
What We're Building Now
Today, we are actively empowering patients and expanding access through a range of impactful programs:
Support Groups: Connecting patients with peer support, education, and community.
Educational Resources: Providing webinars, expert Q&As, infographics, and online guides.
Advocacy Campaigns: Raising awareness and driving policy change for affordability and access.
Healthcare Network Expansion: Growing partnerships with clinics, physicians, and healthcare allies to improve patient pathways.
Each initiative strengthens our collective impact — one step at a time.
Future Initiatives
New approvals. New hope. No barriers.
We’re just getting started. As GLP-1 medications expand into new indications—including weight management, cardiovascular health, and the treatment of chronic conditions—the need for strong, coordinated advocacy is more urgent than ever.
Looking Ahead, Our Priorities Include:
Educational Outreach: Launching a nationwide campaign with expert-driven content to raise awareness and improve access to reliable, science-based information.
A Health Access Expo: A national event bringing together patients and healthcare professionals to spotlight innovation, impact, and affordability.
Policy Advocacy: Advancing legislative efforts to ensure affordability, access, and transparency in GLP-1 availability.
Community Building: Establishing local chapters and hosting regional events to foster connection, support, and shared impact.
